AbstractThe hematopoietic cell transplantation specific comorbidity index (HCT-CI) has been recently proposed to predict the probability of nonrelapse mortality (NRM) and overall survival (OS) in allogeneic HCT recipients while taking into account any pretransplant comorbidity. We tested the validity of the HCT-CI in a cohort of 373 adult HCT recipients (184 matched-related donor and 189 unrelated umbilical cord blood) who received a myeloablative (N = 150) or nonmyeloablative (N = 223) conditioning regimen. HCT-CI scores of 0, 1, 2, and ≥3 were present in 58 (16%), 56 (15%), 64 (17%), and 195 (52%) patients, respectively. Pulmonary conditions were the most common comorbidity. Cumulative incidence of NRM at 2 years was 10%, 20%, 24%, and 28...
In the context of allogeneic hematopoietic cell transplantation (allo-HSCT), comorbidities are an im...
International audienceRisk assessment of allogeneic hematopoietic cell transplantation (allo-HCT) is...
Outcomes of hematopoietic stem cell transplantation (HSCT) are influenced by comorbidities, disease ...
AbstractRecent advances in allogeneic hematopoietic stem cell transplantation have led to increasing...
AbstractThe hematopoietic cell transplantation specific comorbidity index (HCT-CI) has been recently...
We previously reported that the Charlson Comorbidity Index (CCI) was useful for predicting outcomes ...
We previously reported that the Charlson Comorbidity Index (CCI) was useful for predicting outcomes ...
Comorbidity indexes (CI) have been reported to predict non-relapse mortality (NRM) and overall survi...
AbstractThe hematopoietic cell transplantation comorbidity index (HCT-CI), a weighted index of 17 pr...
AbstractProspective validation of the hematopoietic cell transplantation–comorbidity index (HCT-CI) ...
AbstractAutologous hematopoietic stem cell transplantation (AHCT) improves survival in patients with...
The hematopoietic cell transplantation specific comorbidity index (HCT-CI) has been developed to ide...
To validate the predictive ability of the Hematopoietic Cell Transplantation-Specific Comorbidity In...
We previously reported that the Charlson Comorbidity Index (CCI) was useful for predicting outcomes ...
Comorbidity indexes (CI) have been reported to predict non-relapse mortality (NRM) and overall survi...
In the context of allogeneic hematopoietic cell transplantation (allo-HSCT), comorbidities are an im...
International audienceRisk assessment of allogeneic hematopoietic cell transplantation (allo-HCT) is...
Outcomes of hematopoietic stem cell transplantation (HSCT) are influenced by comorbidities, disease ...
AbstractRecent advances in allogeneic hematopoietic stem cell transplantation have led to increasing...
AbstractThe hematopoietic cell transplantation specific comorbidity index (HCT-CI) has been recently...
We previously reported that the Charlson Comorbidity Index (CCI) was useful for predicting outcomes ...
We previously reported that the Charlson Comorbidity Index (CCI) was useful for predicting outcomes ...
Comorbidity indexes (CI) have been reported to predict non-relapse mortality (NRM) and overall survi...
AbstractThe hematopoietic cell transplantation comorbidity index (HCT-CI), a weighted index of 17 pr...
AbstractProspective validation of the hematopoietic cell transplantation–comorbidity index (HCT-CI) ...
AbstractAutologous hematopoietic stem cell transplantation (AHCT) improves survival in patients with...
The hematopoietic cell transplantation specific comorbidity index (HCT-CI) has been developed to ide...
To validate the predictive ability of the Hematopoietic Cell Transplantation-Specific Comorbidity In...
We previously reported that the Charlson Comorbidity Index (CCI) was useful for predicting outcomes ...
Comorbidity indexes (CI) have been reported to predict non-relapse mortality (NRM) and overall survi...
In the context of allogeneic hematopoietic cell transplantation (allo-HSCT), comorbidities are an im...
International audienceRisk assessment of allogeneic hematopoietic cell transplantation (allo-HCT) is...
Outcomes of hematopoietic stem cell transplantation (HSCT) are influenced by comorbidities, disease ...